PTH and osteoporosis: Among antiresorptive drugs, bisphosphonates and denosumab are the most widely used in clinical practice; whereas molecules structurally related to parathormone (PTH), such as teriparatide and abaloparatide, are anabolic (i.e., bone-forming) agents frequently used to treat osteoporosis [1,2].